Search research articles
Contact Us
Filters
Showing results (101-110 of 346) with videos related to
Page
of 35
Sort By:
American Journal of Hematology
|
March 29, 2021
An effective chemotherapy-free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
Nicholas J Short, Marina Konopleva, Tapan Kadia, et al.
Blood Advances
|
August 31, 2021
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse
Bachar Samra, Joseph D Khoury, Kiyomi Morita, et al.
British Journal of Haematology
|
May 9, 2024
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease
Wei-Ying Jen, Hagop Kantarjian, Tapan M Kadia, et al.
Blood Advances
|
September 30, 2021
Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia
David McCall, Michael Roth, Kris M Mahadeo, et al.
Cancer
|
May 28, 2024
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase
Fadi G Haddad, Koji Sasaki, Lewis Nasr, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 13, 2025
Inferior Outcomes in Acute Lymphoblastic Leukemia With Translocation (14;18)
Diane Habib, Elias Jabbour, Alex Bataller, et al.
Blood Advances
|
February 24, 2022
Validation of ALFA 1200 score in patients with AML >60 years treated with double nucleoside-based low-intensity therapy
Sangeetha Venugopal, Gautam Borthakur, Naval Daver, et al.
Leukemia & Lymphoma
|
August 9, 2025
Outcomes and patterns of relapse with ponatinib-based therapy in patients with chronic myeloid leukemia in myeloid blast phase
Omer Karrar, Hagop Kantarjian, Fadi G Haddad, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 2, 2026
Results of Third-Line Therapy in Philadelphia Chromosome-Positive Adult Acute Lymphoblastic Leukemia
Wei-Ying Jen, Elias Jabbour, Eitan Kugler, et al.
American Journal of Hematology
|
November 6, 2018
Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts
Nicholas J Short, Elias Jabbour, Maher Albitar, et al.
Page
of 35
Search research articles
Search
Showing results (101-110 of 346) with videos related to
Sort By:
Page
of 35
American Journal of Hematology
|
March 29, 2021
An effective chemotherapy-free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
Nicholas J Short, Marina Konopleva, Tapan Kadia, et al.
Blood Advances
|
August 31, 2021
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse
Bachar Samra, Joseph D Khoury, Kiyomi Morita, et al.
British Journal of Haematology
|
May 9, 2024
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease
Wei-Ying Jen, Hagop Kantarjian, Tapan M Kadia, et al.
Blood Advances
|
September 30, 2021
Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia
David McCall, Michael Roth, Kris M Mahadeo, et al.
Cancer
|
May 28, 2024
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase
Fadi G Haddad, Koji Sasaki, Lewis Nasr, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 13, 2025
Inferior Outcomes in Acute Lymphoblastic Leukemia With Translocation (14;18)
Diane Habib, Elias Jabbour, Alex Bataller, et al.
Blood Advances
|
February 24, 2022
Validation of ALFA 1200 score in patients with AML >60 years treated with double nucleoside-based low-intensity therapy
Sangeetha Venugopal, Gautam Borthakur, Naval Daver, et al.
Leukemia & Lymphoma
|
August 9, 2025
Outcomes and patterns of relapse with ponatinib-based therapy in patients with chronic myeloid leukemia in myeloid blast phase
Omer Karrar, Hagop Kantarjian, Fadi G Haddad, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 2, 2026
Results of Third-Line Therapy in Philadelphia Chromosome-Positive Adult Acute Lymphoblastic Leukemia
Wei-Ying Jen, Elias Jabbour, Eitan Kugler, et al.
American Journal of Hematology
|
November 6, 2018
Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts
Nicholas J Short, Elias Jabbour, Maher Albitar, et al.
Page
of 35